DESERT HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $174K
- Transactions
- 113
- Companies
- 20
- Average per transaction
- $1,541
Who reported the payments
| Bristol Myers Squibb | $33,345 |
| Roche Products Limited | $23,332 |
| E.r. Squibb & Sons, L.L.C. | $19,508 |
| Cvrx, Inc. | $19,295 |
| Astrazeneca UK Limited | $15,493 |
| Olympus America Inc. | $13,116 |
| Vapotherm Inc | $12,630 |
| AstraZeneca | $9,395 |
| Novocure GmbH | $8,290 |
| Amgen | $6,483 |
| Stryker | $5,915 |
| Johnson & Johnson | $2,285 |
| GT Medical Technologies, Inc | $1,118 |
| Hikma Pharmaceuticals USA | $1,085 |
| Merck | $787 |
| Medline Industries LP | $779 |
| Abbott | $598 |
| SCA Pharmaceuticals, LLC | $553 |
| Eli Lilly | $123 |
| Aesculap, Inc. | $25 |